≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Problems related to care-provider dependency

Endpoint Browser

Z21_PROBL_RELATED_CARE__DEPENDENCY

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z74
  • Cause of death: ICD-10 — Z74

2 out of 7 registries used, show all original rules.

307

4. Check minimum number of events

None

307

5. Include endpoints

None

307

6. Filter based on genotype QC (FinnGen only)

301

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 301 127 174
Unadjusted period prevalence (%) 0.07 0.05 0.08
Median age at first event (years) 76.05 75.79 76.25

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
307
Matched controls
3070
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
+∞
137.0
121
*
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
+∞
74.0
68
*
Z74.1
ICD-10 Finland
Need for assistance with personal care
+∞
56.0
52
*
Z74.8
ICD-10 Finland
Other problems related to care-provider dependency
+∞
46.0
43
*
Z75.5
ICD-10 Finland
Holiday relief care
+∞
43.8
41
*
N03AG01
ATC
valproic acid; systemic, rectal
9.5
38.3
49
60
N05AH03
ATC
olanzapine; systemic
8.5
30.5
42
56
A29
ICPC
General symptom/complaint other
4.5
29.0
90
260
N05AX08
ATC
risperidone; systemic
4.7
28.1
80
216
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.7
25.4
70
183
Z74.9
ICD-10 Finland
Problem related to care-provider dependency, unspecified
+∞
24.3
23
*
A28
ICPC
Limited function/disability NOS
3.5
24.3
123
492
SPAT1229
SPAT
Assessment of need for aid
4.9
23.5
58
138
R51
NOMESCO Finland
Aids services
+∞
23.2
22
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
22.8
95
333
A06AD11
ATC
lactulose; oral
3.3
21.0
107
424
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.3
20.9
63
175
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
20.6
38
69
N05AH04
ATC
quetiapine; oral
3.7
20.0
79
265
L89
ICD-10 Finland
Decubitus ulcer and pressure area
9.0
19.5
25
30
F03
ICD-10 Finland
Unspecified dementia
4.2
18.7
56
154
N02AA05
ATC
oxycodone; systemic
3.1
18.4
104
434
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
17.6
91
359
SPAT1262
SPAT
Handing over of treatment supplies
3.3
17.4
82
306
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
17.3
149
775
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.7
17.2
34
66
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
16.8
86
337
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.0
16.7
53
152
WX704
NOMESCO Finland
Intubation
4.9
15.7
37
84
N05BA04
ATC
oxazepam; oral
2.8
15.6
111
518
N05AA02
ATC
levomepromazine; systemic
6.2
15.2
27
47
N03AE01
ATC
clonazepam; systemic
5.3
14.4
30
61
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.3
14.3
62
218
CA1ME
NOMESCO Finland
Ultrasound oculometry
25.2
14.0
19
8
WZC00, ,
SPAT
3.5
13.9
55
182
N05AD01
ATC
haloperidol; systemic
5.5
13.9
28
55
N05BA06
ATC
lorazepam; systemic, sublingual
4.5
13.3
34
82
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.8
13.3
25
46
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.8
13.2
31
70
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.4
13.0
35
88
N30.0
ICD-10 Finland
Acute cystitis
3.0
12.6
65
252
K90
ICPC
Stroke/cerebrovascular accident
5.7
12.5
24
45
R53
ICD-10 Finland
Malaise and fatigue
2.5
12.3
106
534
N06AB04
ATC
citalopram; systemic
2.7
12.2
86
393
J01MA02
ATC
ciprofloxacin; systemic
2.4
12.2
152
902
N03AF01
ATC
carbamazepine; oral, rectal
4.2
12.2
34
88
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
12.2
38
107
SPAT1255
SPAT
Intravenous administration of medicine
3.9
12.0
37
103
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.2
11.9
25
51
SPAT1249
SPAT
Treatment-related counselling outside office
2.4
11.8
123
674
P29
ICPC
Psychological sympt/compl other
5.0
11.6
26
56
N05BA01
ATC
diazepam; systemic, rectal
3.0
11.5
59
228
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
5.0
11.2
25
54
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.5
10.8
39
121
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.8
10.7
19
17
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
10.7
76
347
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.6
10.2
19
19
J01EA01
ATC
trimethoprim; systemic
2.3
10.1
109
599
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
10.0
99
524
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
9.9
134
805
C03CA01
ATC
furosemide; systemic
2.2
9.9
167
1094
N03AX12
ATC
[U] gabapentin; oral
2.7
9.9
58
240
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
9.9
29
78
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.4
9.7
37
119
ZYC01, ,
SPAT
3.3
9.5
38
126
N05AX12
ATC
aripiprazole; systemic
12.9
9.5
16
13
Z74.3
ICD-10 Finland
Need for continuous supervision
+∞
9.4
9
*
WX892
NOMESCO Finland
Monitored bed care
3.4
9.4
35
111
A60
ICPC
General and Unspecified, Result test/procedure
4.2
9.2
25
63
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
9.2
37
123
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.9
9.1
48
187
UKC02
NOMESCO Finland
Cystoscopy
2.3
8.7
78
392
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
8.6
92
498
WYA20
NOMESCO Finland
Home visit
4.3
8.4
22
54
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
9.9
8.4
16
17
Z75.0
ICD-10 Finland
Medical services not available in home
+∞
8.4
8
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
8.4
65
307
WX882
NOMESCO Finland
High dependency care
6.8
8.3
20
31
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
8.2
59
268
N03AX14
ATC
levetiracetam; systemic
7.6
8.1
18
25
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.6
8.0
27
80
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.3
7.8
30
97
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
18.9
7.7
11
6
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
4.1
7.6
21
54
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
7.5
18
41
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
7.5
23
64
N06AB06
ATC
sertraline; oral
3.0
7.4
35
128
Z75.8
ICD-10 Finland
Other problems related to medical facilities and other health care
+∞
7.3
7
*
ZYB04, ,
SPAT
30.8
7.2
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
7.0
23
67
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
14.2
6.9
11
8
SPAT1193
SPAT
Pap smear
4.4
6.8
17
40
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.4
6.8
50
229
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
41.0
6.8
8
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3.9
6.8
20
54
S97
ICPC
Chronic ulcer skin
2.8
6.7
34
129
SPAT1252
SPAT
Overall medication plan or its review
2.9
6.7
32
118
WW200, ,
SPAT
2.0
6.6
83
472
G35
ICD-10 Finland
Multiple sclerosis
12.6
6.6
11
9
N06DX01
ATC
memantine; oral
2.3
6.6
56
273
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.5
6.6
42
180
R40.0
ICD-10 Finland
Somnolence
71.3
6.4
7
*
N05CD07
ATC
temazepam; oral
2.2
6.4
62
319
G20
ICD-10 Finland
Parkinson disease
3.7
6.3
20
57
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.6
6.3
17
32
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.5
6.2
15
24
R33
ICD-10 Finland
Retention of urine
2.4
6.2
46
211
N03AX09
ATC
lamotrigine; oral
6.0
6.2
16
28
ZYC01
NOMESCO Finland
Remote contact by phone
3.9
6.2
18
48
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.1
60
310
SPAT1216
SPAT
Assessment of functional ability
2.1
6.1
63
332
NFQ20
NOMESCO Finland
Amputation of femur
6.9
6.1
14
21
M03BX01
ATC
baclofen; systemic
6.3
6.1
15
25

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Holiday relief care
Z75.5 (45547342)
Need for assistance due to reduced mobility
Z74.0 (45600355)
Need for assistance at home and no other household member able to render care
Z74.2 (45537671)
Need for assistance with personal care
Z74.1 (45581069)
Aids services
R51 (2001310245)
Other problems related to care-provider dependency
Z74.8 (45537672)
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 (2001310246)
Assessment of need for aid
SPAT1229 (2001700330)
memantine; oral
N06DX01 (21604799)
Neurology
13 (38004458)
Sequelae of cerebral infarction
I69.3 (45533476)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
Problem related to care-provider dependency, unspecified
Z74.9 (45585854)
Outpatient Hospital
22 (8756)
Inpatient Visit
IP (9201)
Counselling/guidance promoting independent living
SPAT1222 (2001700323)
General symptom/complaint other
A29 (2002000163)
valproic acid; oral, parenteral, rectal
N03AG01 (21604422)
General Practice
1 (38004446)
Limited function/disability NOS
A28 (2002000162)
Home Visit
OMOP4822459 (581476)
pH of Urine by Test strip
5803-2 (3022621)
oxycodone; oral, parenteral
N02AA05 (21604260)
Specific gravity of Urine by Refractometry
5810-7 (3019150)
Emergency Room Visit
ER (9203)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
Implementation of physical therapy rehabilitation plan
SPAT1223 (2001700324)
lactulose; oral
A06AD11 (21600571)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Inpatient Hospital
21 (8717)
Bacteria identified in Urine by Culture
630-4 (3026008)
Pneumonia, unspecified
J18.9 (45601123)
quetiapine; oral
N05AH04 (21604544)
risperidone; oral, parenteral
N05AX08 (21604559)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
citalopram; oral, parenteral
N06AB04 (21604712)
Emergency Room and Inpatient Visit
ERIP (262)
Comprehensive monitoring of chronic illness
SPAT1250 (2001700351)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
Oxygen saturation in Arterial blood
2708-6 (3016502)
pH of Arterial blood
2744-1 (3019977)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
oxazepam; oral
N05BA04 (21604569)
Outpatient Visit
OP (9202)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
Gas panel - Arterial blood
24336-0 (3019060)
Pharmacy visit
OMOP4822462 (581458)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Essential (primary) hypertension
I10 (45591453)
Bacteria identified in Blood by Culture
600-7 (3023368)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
Psychiatry
26 (38004469)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Lactate [Moles/volume] in Blood
32693-4 (3047181)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
Alzheimer disease with late onset
G30.1 (45552521)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
General Surgery
2 (38004447)
furosemide; oral, parenteral
C03CA01 (21601518)
Base excess in Arterial blood by calculation
1925-7 (3003396)
Assessment of need for services (elderly/care support)
SPAT1217 (2001700318)
CBC panel - Blood by Automated count
58410-2 (40761511)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Chloride [Moles/volume] in Blood
2069-3 (3018572)
Anion gap in Blood by calculation
41276-7 (3039000)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
Internal Medicine
11 (38004456)
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 (40762366)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Platelets [#/volume] in Blood
26515-7 (3007461)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
MCH [Entitic mass]
28539-5 (3035941)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
Case Management Agency
251B00000X (38004193)
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 (40771025)
Hyaline casts [#/volume] in Urine by Automated count
51484-4 (3030981)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
Supine thorax X-ray examination
GD1QA (2001303648)
Laboratory Visit
OMOP4822461 (32036)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
calcium (different salts in combination); oral
A12AA20 (21600872)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
Fall on same level from slipping, tripping and stumbling
W01 (45756243)
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
307 (2001600266)
Functional capacity evaluation
443351003 (40481051)
Office Visit
OMOP4822458 (581477)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
99
190
7.21
53.16
8.1
3.0
6.10
6.17
ph
0.29
92
150
72
167
5.33
30.48
6.0
4.0
—
—
—
0
0
42
57
8.38
30.04
7.6
5.3
11.45
11.29
mmol/l
0.09
42
48
42
57
8.38
30.04
7.6
5.3
103.31
104.42
mmol/l
0.59
42
48
89
255
4.51
29.01
6.5
8.1
122.06
119.70
g/l
0.55
89
246
74
185
4.95
28.57
6.4
5.9
25.54
24.26
mmol/l
1.82
74
173
92
282
4.23
27.26
6.8
7.7
95.82
95.00
%
0.78
92
269
131
548
3.43
24.02
9.7
5.0
1.02
1.02
kg/l
0.24
108
363
93
318
3.76
23.23
7.3
7.2
7.42
7.41
ph
0.38
77
181
92
321
3.66
22.20
7.3
7.1
11.42
11.44
kpa
0.01
92
301
92
321
3.66
22.20
7.3
7.1
5.19
5.09
kpa
0.43
92
301
91
322
3.60
21.41
7.4
7.1
2.55
0.95
mmol/l
5.19
82
262
139
637
3.16
21.39
8.7
4.7
0.00
0.01
estimate
0.50
14
186
46
111
4.70
18.17
7.6
4.6
2.07
1.57
%
2.56
46
99
45
109
4.67
17.68
7.8
4.6
1.02
0.92
%
1.02
45
98
144
781
2.59
14.81
6.6
3.6
—
—
—
0
0
136
730
2.55
14.15
6.3
4.4
—
—
—
0
0
145
865
2.28
11.25
10.0
4.6
0.00
0.07
estimate
1.47
14
175
67
292
2.66
10.32
2.4
1.7
—
—
—
0
0
108
599
2.24
9.69
10.3
3.8
0.00
0.18
estimate
0.58
14
158
169
1139
2.08
8.96
9.4
4.4
0.00
1.50
estimate
0.50
18
200
95
519
2.20
8.71
2.1
1.8
410.78
27857580.06
pmol/l
0.50
90
420
166
1122
2.04
8.61
9.6
4.5
0.00
0.00
estimate
-0.00
17
213
166
1133
2.01
8.26
9.5
4.5
0.00
7.42
estimate
0.50
18
219
86
472
2.14
7.68
3.9
3.1
517.74
541.64
mosm/kgh2o
0.51
80
407
178
1317
1.84
6.27
10.4
5.4
7.25
6.84
mmol/l
1.46
178
1240
63
332
2.13
6.14
3.1
1.9
—
—
—
0
0
138
953
1.81
6.03
5.9
4.7
63.11
48.61
ng/l
0.30
118
737
17
34
5.23
5.97
2.1
1.5
—
—
—
0
0
27
621
0.38
5.74
3.4
3.5
—
—
—
0
0
194
1498
1.80
5.69
9.9
5.4
9122.80
2197.22
e6/l
—
5
46
83
522
1.81
4.75
2.0
1.8
1135.14
1114.28
nmol/l
0.11
71
389
17
55
3.21
4.43
4.6
3.5
—
—
—
0
0
22
83
2.78
4.43
12.3
3.0
25.77
24.89
mmol/l
0.40
22
83
104
715
1.69
4.30
6.7
4.3
7.41
7.39
ph
1.70
86
529
153
1170
1.61
4.11
11.7
7.0
1.21
1.21
mmol/l
0.15
142
967
8
10
8.18
4.08
1.1
1.0
91.63
107.50
pmol/l
—
8
10
16
58
2.86
3.48
1.6
1.4
241.73
352.01
ug/g
1.31
11
33
137
1051
1.55
3.45
6.7
5.1
33.76
34.45
g/l
0.69
130
963
106
778
1.55
3.21
5.3
3.6
86.67
136.97
e6/l
0.23
95
623
96
693
1.56
3.11
2.6
2.4
2.67
3.16
mg/l
1.06
91
592
181
1498
1.51
3.07
9.6
4.9
—
2.87
—
0
7
8
18
4.53
2.81
2.9
1.9
—
—
—
0
0
73
506
1.58
2.79
5.4
4.0
64.53
304.97
ng/l
2.66
63
448
5
6
8.44
2.76
1.4
1.0
—
—
—
0
0
113
864
1.49
2.75
6.1
4.1
191.01
191.60
e6/l
0.00
97
645
7
14
5.09
2.74
1.1
1.7
—
—
—
0
0
27
142
1.99
2.65
2.9
3.3
0.82
0.93
%
0.12
22
61
92
685
1.49
2.52
2.5
2.4
—
—
—
0
0
96
723
1.48
2.48
7.5
5.8
—
—
—
0
0
9
30
3.06
2.16
2.6
2.8
561.67
479.30
mg
—
9
30
24
131
1.90
2.15
2.6
3.2
0.97
0.53
%
0.57
19
53
19
97
2.02
2.05
1.4
1.3
—
—
—
0
0
41
268
1.61
2.00
4.6
5.1
7.38
7.37
ph
0.37
25
175
40
260
1.62
2.00
1.5
1.3
—
—
—
0
0
68
499
1.47
1.97
1.4
1.3
—
—
—
0
0
11
45
2.50
1.95
1.6
1.6
18.11
25.09
iu/l
0.42
11
36
30
184
1.70
1.87
3.4
2.8
—
—
—
0
0
33
208
1.66
1.86
1.8
2.3
192.36
131.44
ug/g
0.57
28
157
139
1170
1.34
1.78
25.2
19.2
1.40
1.37
inr
0.21
127
974
116
952
1.35
1.75
3.2
2.8
—
—
estimate
—
0
0
8
30
2.71
1.73
2.8
2.3
90.40
88.86
%
—
8
30
65
843
0.71
1.67
19.4
11.9
0.00
0.00
e9/l
0.45
53
683
6
19
3.20
1.67
1.2
1.4
19.48
38.45
ng/l
—
6
19
28
175
1.66
1.64
1.4
1.6
—
—
—
0
0
172
1928
0.75
1.64
5.5
5.9
2.38
2.51
mmol/l
1.23
164
1722
179
1576
1.33
1.64
46.2
23.3
14.34
13.95
%
3.12
179
1551
13
63
2.11
1.62
1.6
1.6
—
—
—
0
0
165
1858
0.76
1.61
4.9
5.1
1.32
1.43
mmol/l
2.87
156
1651
33
484
0.64
1.61
2.4
3.2
1.00
0.83
ug/l
0.38
27
321
31
201
1.60
1.59
1.5
1.5
—
—
—
0
0
111
921
1.32
1.52
6.1
4.1
6.32
6.22
ph
0.40
73
518
19
110
1.78
1.46
3.2
3.0
—
—
—
0
0
9
178
0.49
1.45
1.2
1.4
—
—
—
0
0
168
1874
0.77
1.44
5.0
5.2
4.16
4.39
mmol/l
2.09
158
1685
5
16
3.16
1.44
1.4
1.3
—
—
—
0
0
37
260
1.48
1.35
3.9
5.1
1.57
1.72
mmol/l
0.08
30
206
0
39
0.00
1.34
0.0
1.2
—
0.67
—
0
9
21
130
1.66
1.30
2.5
2.6
—
—
—
0
0
5
18
2.81
1.29
1.0
1.2
—
—
—
0
0
8
37
2.19
1.22
1.4
1.4
—
—
—
0
0
32
224
1.48
1.20
3.1
4.2
4.24
4.33
kpa
0.10
27
212
136
1189
1.26
1.19
14.8
9.0
5.19
4.45
e9/l
1.68
123
1033
161
1780
0.80
1.15
4.5
4.4
1.38
1.25
mmol/l
1.43
153
1566
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
173
1892
0.80
1.09
5.1
5.4
6.28
6.08
mmol/l
0.85
165
1666
6
123
0.48
1.07
12.2
3.9
—
—
—
0
0
51
641
0.75
1.04
7.3
5.8
—
—
—
0
0
31
223
1.43
1.03
8.5
8.6
1.46
1.39
mmol/l
0.14
31
218
7
34
2.08
1.03
1.6
1.2
—
—
—
0
0
53
418
1.32
1.03
5.4
4.5
—
—
—
0
0
29
207
1.44
1.01
5.1
3.6
—
—
—
0
0
6
28
2.16
0.92
1.2
2.8
—
—
—
0
0
7
127
0.54
0.90
1.9
1.4
—
—
—
0
0
10
168
0.58
0.89
1.8
1.6
—
—
—
0
0
6
30
2.02
0.87
11.0
3.5
10.00
12.58
pmol/l
—
6
30
6
30
2.02
0.87
1.8
2.3
32.50
32.37
pg
—
6
30
215
2018
1.22
0.84
37.2
18.5
32.69
28.90
mg/l
0.92
207
1699
50
404
1.28
0.83
3.6
2.6
2.43
2.22
g/l
1.31
50
364
30
225
1.37
0.82
8.7
9.3
—
—
—
0
0
120
1070
1.20
0.81
7.9
5.5
0.67
0.62
e9/l
0.89
108
905
110
973
1.20
0.81
7.5
5.6
59.36
59.55
%
0.05
110
914
33
255
1.33
0.76
2.0
2.9
62.97
63.75
e9/l
0.05
27
204
120
1076
1.19
0.75
8.0
5.5
0.04
0.04
e9/l
0.27
108
916
9
55
1.66
0.74
1.2
1.3
64.22
61.16
mmol/l
—
9
43
6
110
0.54
0.73
2.7
2.0
—
—
—
0
0
7
40
1.77
0.71
1.6
2.4
0.80
0.97
%
—
7
29
5
27
1.87
0.68
2.6
3.1
—
—
—
0
0
6
105
0.56
0.63
1.0
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
28
220
1.30
0.59
1.3
1.2
—
—
—
0
0
18
132
1.39
0.58
3.2
3.3
0.00
0.25
%
0.82
13
53
85
758
1.17
0.56
2.7
2.3
—
—
—
0
0
63
550
1.18
0.53
2.7
3.0
351.74
362.37
umol/l
0.28
58
467
79
703
1.17
0.53
2.0
1.8
20.07
20.23
nmol/l
0.03
73
570
6
100
0.59
0.52
11.5
4.4
25.17
25.66
mmol/l
—
6
93
9
64
1.42
0.52
1.3
1.2
—
—
—
0
0
43
364
1.21
0.51
1.7
1.4
2.34
2.67
g/l
0.55
26
193
18
136
1.34
0.50
1.3
1.1
—
—
—
0
0
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
7
45
1.57
0.49
6.1
2.7
15.43
15.49
%
—
7
45
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
7
46
1.53
0.48
1.9
1.3
—
—
—
0
0
7
46
1.53
0.48
1.9
1.3
—
—
—
0
0
119
1103
1.13
0.45
8.0
5.8
0.19
0.19
e9/l
0.01
107
946
5
31
1.62
0.43
4.0
3.0
17.40
40.87
u/ml
—
5
31
0
15
0.00
0.41
0.0
2.7
—
33.13
—
0
15
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
8
61
1.32
0.40
1.3
1.2
—
3.56
—
0
5
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
10
72
1.40
0.37
5.4
4.6
2.07
1.78
mg/l
—
10
56
10
135
0.73
0.37
4.9
3.3
0.00
0.11
%
—
5
53
212
2047
1.12
0.36
38.0
17.2
—
—
—
0
0
6
42
1.44
0.35
1.0
1.1
22.88
35.42
u/l
—
6
36
14
178
0.78
0.35
10.6
4.2
—
—
—
0
0
20
163
1.24
0.35
11.3
9.3
25.68
24.48
mmol/l
1.00
20
155
27
229
1.20
0.33
2.0
1.4
—
—
—
0
0
32
276
1.18
0.33
2.7
4.1
5.05
47.18
ug/l
0.90
24
240
6
47
1.28
0.32
1.7
1.3
—
—
—
0
0
61
667
0.89
0.30
6.5
3.5
0.69
0.44
e6/l
0.51
50
515
12
93
1.30
0.30
1.4
1.2
149.98
125.85
u/ml
—
6
39
28
242
1.17
0.29
2.0
1.7
—
—
—
0
0
23
269
0.84
0.29
1.6
1.4
—
—
—
0
0
14
113
1.25
0.27
3.9
3.3
25.64
24.57
mmol/l
0.71
14
106
13
160
0.80
0.26
18.1
4.1
1.17
1.22
mmol/l
1.31
13
136
110
1047
1.08
0.23
2.2
2.3
87.60
91.59
pmol/l
0.52
73
552
0
11
0.00
0.21
0.0
2.5
—
5.61
—
0
11
0
12
0.00
0.21
0.0
1.0
—
174.57
—
0
12
155
1501
1.07
0.20
4.7
3.8
14.90
15.16
pmol/l
0.62
146
1301
44
405
1.10
0.20
1.5
1.2
3.87
2.08
u/ml
—
9
95
114
1093
1.07
0.20
8.1
5.6
1.69
1.77
e9/l
0.54
104
958
12
100
1.21
0.18
1.1
1.3
—
38.79
—
0
9
13
111
1.18
0.16
2.1
2.6
—
11.93
—
0
7
9
78
1.16
0.15
6.1
11.7
—
—
—
0
0
75
718
1.06
0.13
3.3
3.2
76.65
52.69
mg/l
0.47
60
482
125
1215
1.05
0.13
3.8
3.3
56.97
55.41
u/l
0.07
117
1118
25
272
0.91
0.12
1.6
1.2
0.97
9.53
u/ml
—
6
81
5
45
1.11
0.10
1.0
1.3
968.00
334.50
pmol/l
—
5
45
46
479
0.95
0.08
1.5
1.8
1.29
1.55
mg/l
0.45
35
388
180
1823
0.97
0.07
6.0
4.9
2.02
2.04
mu/l
0.07
171
1598
32
309
1.04
0.04
1.3
1.3
11.40
37.60
iu/ml
3.43
13
97
73
737
0.99
0.01
3.8
3.9
19.68
9.84
mg/mmol
1.01
45
468
11
104
1.06
0.01
1.5
1.3
241.73
179.40
u/ml
0.14
11
94
12
114
1.05
0.01
1.1
1.4
—
—
—
0
0
36
362
0.99
0.00
5.8
3.2
1.18
1.72
e6/l
0.33
18
195
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
18.80
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
6.38
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
0.00
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
1.00
—
0
5
0
8
0.00
-0.00
0.0
2.9
—
1950.00
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
90
1.00
-0.00
1.8
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.0
—
6.94
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_PROBL_RELATED_CARE__DEPENDENCY – Problems related to care-provider dependency

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).